ARCATUS | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

85 results for “ARCATUS”

Trials

View all 21 →

Not yet recruiting

A1Cantus vs. Placebo

50 participants · First posted May 14, 2026

HCM-AF Ablation With ACUTUS

20 participants · First posted Sep 16, 2019

Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units

30 participants · First posted Jul 21, 2008

Drugs

View all 26 →

Acne (Arcutis)

Palmoplantar (Arcutis)

Rosacea (Arcutis)

Organizations

Arcutis Biotherapeutics

United States

Arbutus Biopharma

United States

Acutus Medical

Belgium

News

View all 30 →

China's NMPA Accepts NDA for ARCATUS for Uveitic Macular Edema

Health Canada Approves Clearside Biomedical's XIPERE for Uveitic Macular Edema Treatment

Health Canada Approves Arcutis' ZORYVE Foam for Seborrheic Dermatitis

Page 1 of 9